{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,23]],"date-time":"2024-03-23T01:25:55Z","timestamp":1711157155629},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,22]]},"DOI":"10.7759\/cureus.56735","type":"journal-article","created":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T22:20:14Z","timestamp":1711146014000},"source":"Crossref","is-referenced-by-count":0,"title":["Efficacy of Continuous Intravenous Fentanyl for Oral Mucosal Pain in Stevens-Johnson Syndrome: A Case Report"],"prefix":"10.7759","author":[{"given":"Mitsuru","family":"Ito","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazushi","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azumi","family":"Hidaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruka","family":"Mukai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aki","family":"Egawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14530","article-title":"U.K. guidelines for the management of Stevens-Johnson syndrome\/toxic epidermal necrolysis in adults 2016","volume":"174","author":"Creamer D","year":"2016","unstructured":"Creamer D, Walsh SA, Dziewulski P, et al.. U.K. guidelines for the management of Stevens-Johnson syndrome\/toxic epidermal necrolysis in adults 2016. Br J Dermatol. 2016, 174:1194-227. 10.1111\/bjd.14530","journal-title":"Br J Dermatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1177\/0884533616642746","article-title":"Nutrition in toxic epidermal necrolysis: a multicenter review","volume":"31","author":"Graves C","year":"2016","unstructured":"Graves C, Faraklas I, Maniatis K, et al.. Nutrition in toxic epidermal necrolysis: a multicenter review. Nutr Clin Pract. 2016, 31:836-40. 10.1177\/0884533616642746","journal-title":"Nutr Clin Pract"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.17267","article-title":"Post-traumatic stress disorder in Stevens-Johnson syndrome and toxic epidermal necrolysis: prevalence and risk factors. A prospective study of 31 patients","volume":"180","author":"Hefez L","year":"2019","unstructured":"Hefez L, Zaghbib K, Sbidian E, et al.. Post-traumatic stress disorder in Stevens-Johnson syndrome and toxic epidermal necrolysis: prevalence and risk factors. A prospective study of 31 patients. Br J Dermatol. 2019, 180:1206-13. 10.1111\/bjd.17267","journal-title":"Br J Dermatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.annder.2011.05.029","article-title":"[Pain management in Stevens-Johnson syndrome, toxic epidermal necrolysis and other blistering diseases]","volume":"138","author":"Valeyrie-Allanore L","year":"2011","unstructured":"Valeyrie-Allanore L, Ingen-Housz-Oro S, Colin A, Thuillot D, Sigal ML, Binhas M. [Pain management in Stevens-Johnson syndrome, toxic epidermal necrolysis and other blistering diseases]. Ann Dermatol Venereol. 2011, 138:694-7. 10.1016\/j.annder.2011.05.029","journal-title":"Ann Dermatol Venereol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1177\/0269216311406313","article-title":"A systematic review of the use of opioid medication for those with moderate to severe cancer pain and renal impairment: a European Palliative Care Research Collaborative opioid guidelines project","volume":"25","author":"King S","year":"2011","unstructured":"King S, Forbes K, Hanks GW, Ferro CJ, Chambers EJ. A systematic review of the use of opioid medication for those with moderate to severe cancer pain and renal impairment: a European Palliative Care Research Collaborative opioid guidelines project. Palliat Med. 2011, 25:525-52. 10.1177\/0269216311406313","journal-title":"Palliat Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.24248\/eahrj.v4i1.617","article-title":"Efficacy and safety of fentanyl compared with morphine among adult patients with cancer: a meta-analysis","volume":"4","author":"Manirakiza A","year":"2020","unstructured":"Manirakiza A, Irakoze L, Manirakiza S, Bizimana P. Efficacy and safety of fentanyl compared with morphine among adult patients with cancer: a meta-analysis. East Afr Health Res J. 2020, 4:8-16. 10.24248\/eahrj.v4i1.617","journal-title":"East Afr Health Res J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00540-016-2268-0","article-title":"Continuous intravenous analgesia with fentanyl or morphine after gynecological surgery: a cohort study","volume":"31","author":"Russo A","year":"2017","unstructured":"Russo A, Grieco DL, Bevilacqua F, et al.. Continuous intravenous analgesia with fentanyl or morphine after gynecological surgery: a cohort study. J Anesth. 2017, 31:51-7. 10.1007\/s00540-016-2268-0","journal-title":"J Anesth"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1310\/hpj4107-659","article-title":"A comparison of a fentanyl, morphine, and hydromorphone patient-controlled intravenous delivery for acute postoperative analgesia: a multicenter study of opioid-induced adverse reactions","volume":"41","author":"Hutchinson R","year":"2006","unstructured":"Hutchinson R, Chon EH, Tucker W, et al.. A comparison of a fentanyl, morphine, and hydromorphone patient-controlled intravenous delivery for acute postoperative analgesia: a multicenter study of opioid-induced adverse reactions. Hosp Pharm. 2006, 41:659-63. 10.1310\/hpj4107-659","journal-title":"Hosp Pharm"},{"key":"ref9","article-title":"Contribution of opioid receptors on primary afferent versus sympathetic neurons to peripheral opioid analgesia","volume":"286","author":"Zhou L","year":"1998","unstructured":"Zhou L, Zhang Q, Stein C, Sch\u00e4fer M. Contribution of opioid receptors on primary afferent versus sympathetic neurons to peripheral opioid analgesia. JPET. 1998, 286:1000-6.","journal-title":"JPET"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25112473","article-title":"On the role of peripheral sensory and gut mu opioid receptors: peripheral analgesia and tolerance","volume":"25","author":"F\u00fcrst S","year":"2020","unstructured":"F\u00fcrst S, Z\u00e1dori ZS, Z\u00e1dor F, et al.. On the role of peripheral sensory and gut mu opioid receptors: peripheral analgesia and tolerance. Molecules. 2020, 25:2473. 10.3390\/molecules25112473","journal-title":"Molecules"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0042616","article-title":"Morphine stimulates cell migration of oral epithelial cells by delta-opioid receptor activation","volume":"7","author":"Charbaji N","year":"2012","unstructured":"Charbaji N, Sch\u00e4fer-Korting M, K\u00fcchler S. Morphine stimulates cell migration of oral epithelial cells by delta-opioid receptor activation. PLoS One. 2012, 7:e42616. 10.1371\/journal.pone.0042616","journal-title":"PLoS One"},{"key":"ref12","article-title":"[Continuous intravenous infusion of fentanyl for pain due to stomatitis, pharyngitis, and esophagitis after hematopoietic stem cell transplantation]","volume":"6","author":"Kamimura T","year":"2011","unstructured":"Kamimura T, Chong Y, Ito Y. [Continuous intravenous infusion of fentanyl for pain due to stomatitis, pharyngitis, and esophagitis after hematopoietic stem cell transplantation]. Palliat Care. 2011, 6:246-52.","journal-title":"Palliat Care"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-014-2419-5","article-title":"Efficacy and safety of transdermal fentanyl for the treatment of oral mucositis pain caused by chemoradiotherapy in patients with esophageal squamous cell carcinoma","volume":"23","author":"Xing SZ","year":"2015","unstructured":"Xing SZ, Zhang Y. Efficacy and safety of transdermal fentanyl for the treatment of oral mucositis pain caused by chemoradiotherapy in patients with esophageal squamous cell carcinoma. Support Care Cancer. 2015, 23:753-9. 10.1007\/s00520-014-2419-5","journal-title":"Support Care Cancer"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S60187","article-title":"Transdermal fentanyl for pain due to chemoradiotherapy-induced oral mucositis in nasopharyngeal cancer patients: evaluating efficacy, safety, and improvement in quality of life","volume":"8","author":"Guo SP","year":"2014","unstructured":"Guo SP, Wu SG, Zhou J, et al.. Transdermal fentanyl for pain due to chemoradiotherapy-induced oral mucositis in nasopharyngeal cancer patients: evaluating efficacy, safety, and improvement in quality of life. Drug Des Devel Ther. 2014, 8:497-503. 10.2147\/DDDT.S60187","journal-title":"Drug Des Devel Ther"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1517\/14656560802504508","article-title":"Efficacy and safety of transdermal fentanyl for treatment of oral mucositis pain caused by chemotherapy","volume":"9","author":"Cai Q","year":"2008","unstructured":"Cai Q, Huang H, Sun X, Xia Z, Li Y, Lin X, Guo Y. Efficacy and safety of transdermal fentanyl for treatment of oral mucositis pain caused by chemotherapy. Expert Opin Pharmacother. 2008, 9:3137-44. 10.1517\/14656560802504508","journal-title":"Expert Opin Pharmacother"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2005.11.038","article-title":"Effectiveness of transdermal fentanyl patch for treatment of acute pain due to oral mucositis in patients receiving stem cell transplantation","volume":"37","author":"Kim JG","year":"2005","unstructured":"Kim JG, Sohn SK, Kim DH, et al.. Effectiveness of transdermal fentanyl patch for treatment of acute pain due to oral mucositis in patients receiving stem cell transplantation. Transplant Proc. 2005, 37:4488-91. 10.1016\/j.transproceed.2005.11.038","journal-title":"Transplant Proc"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/0885-3924(92)90049-n","article-title":"System functionality and physicochemical model of fentanyl transdermal system","volume":"7","author":"Gupta SK","year":"1992","unstructured":"Gupta SK, Southam M, Gale R, et al.. System functionality and physicochemical model of fentanyl transdermal system. J Pain Symptom Manag. 1992, 7:17-26. 10.1016\/0885-3924(92)90049-n","journal-title":"J Pain Symptom Manag"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmn.2019.06.007","article-title":"American Society for Pain Management Nursing guidelines on monitoring for opioid-induced advancing sedation and respiratory depression: revisions","volume":"21","author":"Jungquist CR","year":"2020","unstructured":"Jungquist CR, Quinlan-Colwell A, Vallerand A, et al.. American Society for Pain Management Nursing guidelines on monitoring for opioid-induced advancing sedation and respiratory depression: revisions. Pain Manag Nurs. 2020, 21:7-25. 10.1016\/j.pmn.2019.06.007","journal-title":"Pain Manag Nurs"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0000000000004788","article-title":"Prediction of opioid-induced respiratory depression on inpatient wards using continuous capnography and oximetry: an international prospective, observational trial","volume":"131","author":"Khanna AK","year":"2020","unstructured":"Khanna AK, Bergese SD, Jungquist CR, et al.. Prediction of opioid-induced respiratory depression on inpatient wards using continuous capnography and oximetry: an international prospective, observational trial. Anesth Analg. 2020, 131:1012-24. 10.1213\/ANE.0000000000004788","journal-title":"Anesth Analg"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097\/PTS.0000000000001003","article-title":"Continuous monitoring detected respiratory depressive episodes in proximity to adverse respiratory events during the PRODIGY trial","volume":"18","author":"Kor JJ","year":"2022","unstructured":"Kor JJ, Sprung J, Khanna AK, Weingarten TN. Continuous monitoring detected respiratory depressive episodes in proximity to adverse respiratory events during the PRODIGY trial. J Patient Saf. 2022, 18:738-41. 10.1097\/PTS.0000000000001003","journal-title":"J Patient Saf"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/227219-efficacy-of-continuous-intravenous-fentanyl-for-oral-mucosal-pain-in-stevens-johnson-syndrome-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T22:20:17Z","timestamp":1711146017000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/227219-efficacy-of-continuous-intravenous-fentanyl-for-oral-mucosal-pain-in-stevens-johnson-syndrome-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,22]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.56735","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3,22]]}}}